Literature DB >> 25840998

Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients.

Julia Hoffmann1, Leigh M Marsh1, Mario Pieper2, Elvira Stacher3, Bahil Ghanim4, Gabor Kovacs5, Peter König2, Heinrike Wilkens6, Hans Michael Haitchi7, Gerald Hoefler8, Walter Klepetko9, Horst Olschewski10, Andrea Olschewski11, Grazyna Kwapiszewska12.   

Abstract

Alterations in extracellular matrix (ECM) have been implicated in the pathophysiology of pulmonary hypertension. Here, we have undertaken a compartment-specific study to elucidate the expression profile of collagens and their processing enzymes in donor and idiopathic pulmonary arterial hypertension (IPAH) pulmonary arteries. Predominant intimal, but also medial and perivascular, remodeling and reduced lumen diameter were detected in IPAH pulmonary arteries. Two-photon microscopy demonstrated accumulation of collagen fibers. Quantification of collagen in pulmonary arteries revealed collagen accumulation mainly in the intima of IPAH pulmonary arteries compared with donors. Laser capture-microdissected pulmonary artery profiles (intima+media and perivascular tissue) were analyzed by real-time PCR for ECM gene expression. In the intima+media of IPAH vessels, collagens (COL4A5, COL14A1, and COL18A1), matrix metalloproteinase (MMP) 19, and a disintegrin and metalloprotease (ADAM) 33 were higher expressed, whereas MMP10, ADAM17, TIMP1, and TIMP3 were less abundant. Localization of COLXVIII, its cleavage product endostatin, and MMP10, ADAM33, and TIMP1 was confirmed in pulmonary arteries by immunohistochemistry. ELISA for collagen XVIII/endostatin demonstrated significantly elevated plasma levels in IPAH patients compared with donors, whereas circulating MMP10, ADAM33, and TIMP1 levels were similar between the two groups. Endostatin levels were correlated with pulmonary arterial wedge pressure, and established prognostic markers of IPAH, right atrial pressure, cardiac index, 6-min walking distance, NH2-terminal pro-brain natriuretic peptide, and uric acid. Expression of unstudied collagens, MMPs, ADAMs, and TIMPs were found to be significantly altered in IPAH intima+media. Elevated levels of circulating collagen XVIII/endostatin are associated with markers of a poor prognosis.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  collagen XVIII; endostatin; laser microdissection; vascular fibrosis; vascular remodeling

Mesh:

Substances:

Year:  2015        PMID: 25840998      PMCID: PMC4437007          DOI: 10.1152/ajplung.00383.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  63 in total

Review 1.  Pathobiology of pulmonary hypertension. Extracellular matrix.

Authors:  M Rabinovitch
Journal:  Clin Chest Med       Date:  2001-09       Impact factor: 2.878

2.  Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor.

Authors:  K N Cowan; A Heilbut; T Humpl; C Lam; S Ito; M Rabinovitch
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 3.  Collagens--structure, function, and biosynthesis.

Authors:  K Gelse; E Pöschl; T Aigner
Journal:  Adv Drug Deliv Rev       Date:  2003-11-28       Impact factor: 15.470

4.  Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.

Authors:  G G Pietra; W D Edwards; J M Kay; S Rich; J Kernis; B Schloo; S M Ayres; E H Bergofsky; B H Brundage; K M Detre
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

5.  Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.

Authors:  R M Tuder; M Chacon; L Alger; J Wang; L Taraseviciene-Stewart; Y Kasahara; C D Cool; A E Bishop; M Geraci; G L Semenza; M Yacoub; J M Polak; N F Voelkel
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

6.  Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases.

Authors:  R Nicholson; G Murphy; R Breathnach
Journal:  Biochemistry       Date:  1989-06-13       Impact factor: 3.162

7.  Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy.

Authors:  Kazuhiro Matsui; Yasuo Takano; Zu-Xi Yu; Joanne Eunhee Suh Hi; William G Stetler-Stevenson; William D Travis; Victor J Ferrans
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

8.  Reduction of chronic hypoxic pulmonary hypertension in the rat by an inhibitor of collagen production.

Authors:  J S Kerr; C L Ruppert; C A Tozzi; J A Neubauer; H M Frankel; S Y Yu; D J Riley
Journal:  Am Rev Respir Dis       Date:  1987-02

9.  Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans.

Authors:  Guoying Yu; Elisabetha Kovkarova-Naumovski; Paul Jara; Anil Parwani; Daniel Kass; Victor Ruiz; Carlos Lopez-Otín; Ivan O Rosas; Kevin F Gibson; Sandra Cabrera; Remedios Ramírez; Samuel A Yousem; Thomas J Richards; Lara J Chensny; Moisés Selman; Naftali Kaminski; Annie Pardo
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

10.  Interaction of endostatin with integrins implicated in angiogenesis.

Authors:  M Rehn; T Veikkola; E Kukk-Valdre; H Nakamura; M Ilmonen; C Lombardo; T Pihlajaniemi; K Alitalo; K Vuori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

View more
  29 in total

1.  Functional Impact of Human Genetic Variants of COL18A1/Endostatin on Pulmonary Endothelium.

Authors:  Alice M Goyanes; Aigul Moldobaeva; Mery Marimoutou; Lidenys C Varela; Lan Wang; Laura F Johnston; Meena M Aladdin; Grace L Peloquin; Bo S Kim; Mahendra Damarla; Karthik Suresh; Takahiro Sato; Todd M Kolb; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2020-04       Impact factor: 6.914

Review 2.  Update in Pulmonary Vascular Disease 2015.

Authors:  Bradley A Maron; Mark T Gladwin; Marc A Simon
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

Review 3.  Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.

Authors:  Rubin M Tuder; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-18       Impact factor: 5.464

Review 4.  Update on novel targets and potential treatment avenues in pulmonary hypertension.

Authors:  John C Huetsch; Karthik Suresh; Meghan Bernier; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-02       Impact factor: 5.464

Review 5.  Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension.

Authors:  Thenappan Thenappan; Stephen Y Chan; E Kenneth Weir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

6.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

Review 7.  Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both.

Authors:  Jeffrey D Marshall; Isabel Bazan; Yi Zhang; Wassim H Fares; Patty J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

8.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

9.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

10.  Arterial Wall Stiffening in Caveolin-1 Deficiency-Induced Pulmonary Artery Hypertension in Mice.

Authors:  J Moreno; D Escobedo; C Calhoun; C Jourdan Le Saux; H C Han
Journal:  Exp Mech       Date:  2020-10-14       Impact factor: 2.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.